Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMCOS: Chloramphenicol vs Ciprofloxacin for Otorrhea Resolution in CSOM
2026-525540-15-00Phase 3Authorised
- Sponsor
- IRBLleida
- Start
- Jun 2026
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic suppurative otitis media (CSOM) comparing Topical ciprofloxacin (Cetraxal ótico) with Topical chloramphenicol (2 arms). Primary endpoint: Complete resolution of otorrhoea at Day 14. Planned start Jun 2026; status: authorised.
02
Drugs
ciprofloxacinchloramphenicol
03
Conditions
chronic suppurative otitis media (CSOM)
Beyond the preview
Go deeper on 2026-525540-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525540-15-00.